Coexistence of Incontinentia Pigmenti and Pituitary Aplasia in a Female Child

Incontinentia pigmenti (IP) is a rare X-linked dominant neurocutaneous ectodermal disorder. It is caused by IKBKG gene mutations, leading to nuclear factor-kappa B (NF-kB) signaling pathway dysfunction. Skin involvement occurs in almost all patients. IP may also involve teeth, eyes, hair, central nervous system, bone structures, skeletal musculature and immune system. However, endocrine involvement, and specifically the coexistence of IP with complete pituitary aplasia, has not been previously documented in a patient with genetically confirmed IP. We describe a four-year-old female with genetically confirmed IP referred to Paediatric Endocrinology clinic due to short stature and poor growth velocity. Investigation revealed pituitary aplasia with ectopic neurohypophysis. The patient initiated hormone replacement therapy with recombinant human growth hormone and hydrocortisone, followed separately by desmopressin, with significant clinical improvement and no exacerbation of cutaneous manifestations. To our knowledge, this is the first documented case of complete pituitary aplasia in a patient with genetically confirmed IP, with a three-year clinical follow-up.

Authors

Publication Details

Journal
Cureus
Published
2026-06-28
DOI
https://doi.org/10.7759/cureus.111668
Primary Topic
Genetic and rare skin diseases.
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Coexistence of Incontinentia Pigmenti and Pituitary Aplasia in a Female Child

Gonçalo Passos Croca, Patrícia Veríssimo, Marta Valério, Rita Justo Pereira et al.
Cureus
Genetic and rare skin diseases.
article

Coexistence of Incontinentia Pigmenti and Pituitary Aplasia in a Female Child

Gonçalo Passos Croca, Patrícia Veríssimo, Marta Valério, Rita Justo Pereira, Lurdes Lopes
article en

Abstract

Incontinentia pigmenti (IP) is a rare X-linked dominant neurocutaneous ectodermal disorder. It is caused by IKBKG gene mutations, leading to nuclear factor-kappa B (NF-kB) signaling pathway dysfunction. Skin involvement occurs in almost all patients. IP may also involve teeth, eyes, hair, central nervous system, bone structures, skeletal musculature and immune system. However, endocrine involvement, and specifically the coexistence of IP with complete pituitary aplasia, has not been previously documented in a patient with genetically confirmed IP. We describe a four-year-old female with genetically confirmed IP referred to Paediatric Endocrinology clinic due to short stature and poor growth velocity. Investigation revealed pituitary aplasia with ectopic neurohypophysis. The patient initiated hormone replacement therapy with recombinant human growth hormone and hydrocortisone, followed separately by desmopressin, with significant clinical improvement and no exacerbation of cutaneous manifestations. To our knowledge, this is the first documented case of complete pituitary aplasia in a patient with genetically confirmed IP, with a three-year clinical follow-up.

Cureus
Gender equality, Zero hunger
Openalex Percentile: Top 7%
Genetic and rare skin diseases.
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.